1998
DOI: 10.1161/01.res.83.8.824
|View full text |Cite
|
Sign up to set email alerts
|

p38 Kinase Is a Negative Regulator of Angiotensin II Signal Transduction in Vascular Smooth Muscle Cells

Abstract: Activation of the Na /H exchanger isoform-1 (NHE-1) by angiotensin II is an early signal transduction event that may regulate vascular smooth muscle cell (VSMC) growth and migration. Many signal transduction events stimulated by angiotensin II are mediated by the mitogen-activated protein (MAP) kinases. To define their roles in angiotensin II-mediated NHE-1 activity, VSMCs were treated with angiotensin II and the activities of p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinases 1 and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
80
3
14

Year Published

2000
2000
2008
2008

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 131 publications
(106 citation statements)
references
References 41 publications
9
80
3
14
Order By: Relevance
“…These include studies from isolated hepatocytes that suggest a preconditioning effect limiting increases in [Na ϩ ] i during hypoxia is mediated by NO through cGK and p38 MAPK (11) and furthermore that atrial natriuretic peptide diminishes hypoxia-induced increases in [Na ϩ ] i by a similar pathway that inhibits NHE1 (10). These results are also consistent with studies that suggest activation of p38 MAPK inhibits the response of NHE1 to angiotensin II in vascular smooth muscle cells by phosphorylating the NHE1 at serine/threonine residues located between amino acids 671 and 714 (27).…”
Section: Discussionsupporting
confidence: 88%
“…These include studies from isolated hepatocytes that suggest a preconditioning effect limiting increases in [Na ϩ ] i during hypoxia is mediated by NO through cGK and p38 MAPK (11) and furthermore that atrial natriuretic peptide diminishes hypoxia-induced increases in [Na ϩ ] i by a similar pathway that inhibits NHE1 (10). These results are also consistent with studies that suggest activation of p38 MAPK inhibits the response of NHE1 to angiotensin II in vascular smooth muscle cells by phosphorylating the NHE1 at serine/threonine residues located between amino acids 671 and 714 (27).…”
Section: Discussionsupporting
confidence: 88%
“…32,33 The possible involvement of p38 MAPK in down-modulating Na ϩ /H ϩ exchanger is suggested by the observation that p38 MAPK is able to phosphorylate a fusion protein containing the 625 to 747 amino acid sequence of Na ϩ /H ϩ exchanger isoform 1 and that Na ϩ /H ϩ exchanger isoform 1 phosphorylation affects Na ϩ exchange activity. 34 These observations do not exclude that ANP-mediated signals might also activate other cytoprotective mechanisms, because NPs have been shown to modulate cell apoptosis in various tissues. 35 In conclusion, the results show that ANP is capable of increasing hepatocyte tolerance to hypoxia by activating 2 independent signal pathways: one mediated by cGMP and cGK and the other involving G i protein, phospholipase C, and PKC-␦.…”
Section: Discussionmentioning
confidence: 98%
“…cPLA2, Na+/H+ exchanger isoform-1 (NHE-1), tau and keratin 8 have also been reported as substrates for p38α [78][79][80][81]. Furthermore, stathmin is another substrate for p38α [27].…”
Section: Other Types Of Substrates For P38mentioning
confidence: 99%